RO 7058584

Drug Profile

RO 7058584

Alternative Names: RG 7945; RO7058584

Latest Information Update: 08 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche
  • Class Antiglaucomas
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Open-angle glaucoma

Most Recent Events

  • 26 Apr 2018 Discontinued - Phase-I for Open angle glaucoma in USA (Topical)
  • 21 Dec 2017 Roche completes a phase I trial in Open angle glaucoma in USA (Topical, Drops) (NCT03293992)
  • 01 Oct 2017 Phase-I clinical trials in Open angle glaucoma in USA (Topical, Drops) (NCT03293992)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top